SINOPHARM (01099): On November 4, 2026, JPMorgan Chase & Co. disposed of 579,714 shares of SINOPHARM off-exchange at an average of HKD 16.7096 per share, involving about HKD 9.69 million, cutting its holding below 5%. As an off-exchange transaction settled in cash, it was not matched on the SEHK open market and therefore not a direct secondary-market dealing.
Prior to the disposal, JPMorgan Chase & Co.’s long position in SINOPHARM was 67.47 million shares, representing 5.02%; following the disposal, the holding changed to 66.89 million shares, with the long position ratio falling to 4.98%.